Nippon Kayaku Co Ltd (4272):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Nippon Kayaku Co Ltd (4272) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9909
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nippon Kayaku Co Ltd (Nippon Kayaku) is a chemical company, which undertakes the development, manufacturing and sale of functional chemicals, pharmaceuticals and safety systems. The company’s product portfolio includes epoxy resins, UV-curing type resins, optical functional films, colors for inkjet printers, catalysts, pharmaceuticals, active pharmaceutical ingredients (APIs) and intermediates, diagnostic drugs, safety systems such as airbag inflators, micro gas generators for seatbelt pretensioners, squibs, agrochemicals, dyes and others. The company also offers real estate leasing and contract manufacturing to pharmaceutical companies. It has subsidiaries in companies in North America, Europe and Asia. Nippon Kayaku is headquartered in Chiyoda-ku, Tokyo, Japan.

Nippon Kayaku Co Ltd (4272) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nippon Kayaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nippon Kayaku Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nippon Kayaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nippon Kayaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nippon Kayaku Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Nippon Kayaku Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nippon Kayaku Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Nippon Kayaku Enters into Agreement with Celltrion Healthcare 11
Mitsubishi Gas Chemical and Nippon Kayaku Form Joint Venture 12
Licensing Agreements 13
Eiger BioPharma Enters into Licensing Agreement with Nippon Kayaku 13
Nippon Kayaku Co Ltd – Key Competitors 14
Nippon Kayaku Co Ltd – Key Employees 15
Nippon Kayaku Co Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 20
Recent Developments 21
Clinical Trials 21
Jan 16, 2018: Eiger BioPharmaceuticals Announces Phase 2 LIBERTY Study in Pulmonary Arterial Hypertension Did Not Meet Primary Endpoint 21
Jan 04, 2018: Eiger BioPharmaceuticals Completes Enrollment of Phase 2 ULTRA Study of Ubenimex in Primary and Secondary Lymphedema Patients 22
May 17, 2017: Eiger Announces Results Demonstrating Benefit of Ubenimex and Leukotriene B4 (LTB4) Modulation in Experimental Lymphedema 23
May 15, 2017: Eiger BioPharmaceuticals Completes Enrollment of Phase 2 LIBERTY Study of Ubenimex in Pulmonary Arterial Hypertension 24
May 04, 2017: Eiger BioPharmaceuticals to Host Key Opinion Leader Event Addressing Need for Novel Mechanisms in the Treatment of Pulmonary Arterial Hypertension (PAH) on May 10th in New York City 25
Jan 03, 2017: Eiger Announces First Patient Dosed in Open-Label Extension of Phase 2 LIBERTY Study of Ubenimex in Pulmonary Arterial Hypertension 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Nippon Kayaku Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Nippon Kayaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nippon Kayaku Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nippon Kayaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nippon Kayaku Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Nippon Kayaku Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Nippon Kayaku Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nippon Kayaku Enters into Agreement with Celltrion Healthcare 11
Mitsubishi Gas Chemical and Nippon Kayaku Form Joint Venture 12
Eiger BioPharma Enters into Licensing Agreement with Nippon Kayaku 13
Nippon Kayaku Co Ltd, Key Competitors 14
Nippon Kayaku Co Ltd, Key Employees 15
Nippon Kayaku Co Ltd, Other Locations 17
Nippon Kayaku Co Ltd, Subsidiaries 18
Nippon Kayaku Co Ltd, Joint Venture 20

List of Figures
Nippon Kayaku Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nippon Kayaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nippon Kayaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nippon Kayaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nippon Kayaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nippon Kayaku Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nippon Kayaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nippon Kayaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nippon Kayaku Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Nippon Kayaku Co Ltd (4272):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Regis Healthcare Ltd:企業の戦略・SWOT・財務情報
    Regis Healthcare Ltd - Strategy, SWOT and Corporate Finance Report Summary Regis Healthcare Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bafna Pharmaceuticals Ltd (BAFNAPHARM)-製薬・医療分野:企業M&A・提携分析
    Summary Bafna Pharmaceuticals Ltd (Bafna Pharmaceuticals) is a pharmaceutical company which manufactures and markets pharmaceutical products. The company’s operations include domestic marketing, international marketing, international export and business development. Its products comprise raricap, ra …
  • Mytilineos Holdings Sa
    Mytilineos Holdings Sa - Strategy, SWOT and Corporate Finance Report Summary Mytilineos Holdings Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Innovacell Biotechnologie AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Innovacell Biotechnologie AG (Innovacell) is a biotechnology company that focuses on the development of therapeutic products. The company offers personalized cell therapy products for the treatment of incontinence. It provides medical products such as ICES13 and ICEF15. Innovacell’s products …
  • Sino Hotels (Holdings) Limited:企業の戦略・SWOT・財務分析
    Sino Hotels (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Sino Hotels (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Anteo Diagnostics Ltd (ADO):企業の財務・戦略的SWOT分析
    Anteo Diagnostics Ltd (ADO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Canfor Corporation (CFP):企業の財務・戦略的SWOT分析
    Canfor Corporation (CFP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Toa Corp (1885):企業の財務・戦略的SWOT分析
    Toa Corp (1885) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Fossil Group, Inc.:企業の戦略・SWOT・財務情報
    Fossil Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Fossil Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • DNO ASA (DNO):石油・ガス:M&Aディール及び事業提携情報
    Summary DNO ASA (DNO) is an oil and gas company that provides mineral properties exploration and development services. The company's services include selective and targeted drilling, fractured carbonate plays that are characteristic of the MENA region. It also provides operations in petroleum, shipp …
  • Addvalue Technologies Limited (A31):企業の財務・戦略的SWOT分析
    Addvalue Technologies Limited (A31) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Abano Healthcare Group Ltd (ABA)-製薬・医療分野:企業M&A・提携分析
    Summary Abano Healthcare Group Ltd (Abano Healthcare), formerly ElderCare New Zealand Ltd is a healthcare service provider that offers Dental, Audiology, Radiology and medical services. The company also operates business in community pathology and radiology sector. It operates businesses in sectors …
  • Lloyds Banking Group Plc:企業の戦略・SWOT・財務分析
    Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report Summary Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Anthelio Healthcare Solutions Inc.-医療機器分野:企業M&A・提携分析
    Summary Anthelio Healthcare Solutions Inc. (Anthelio), formerly PHNS Inc., is a healthcare IT service company that offers information technology and business process services to hospitals, physician practice groups and other healthcare providers. The company’s suite of software solutions include int …
  • E-CO Energi Holding AS:企業の戦略的SWOT分析
    E-CO Energi Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Prothena Corp Plc (PRTA):企業の財務・戦略的SWOT分析
    Summary Prothena Corp Plc (Prothena) is a clinical biotechnology company, which discovers, develops and markets novel medicines that are indicated for the treatment of diseases associated with neuroscience and orphan diseases. The company develops monoclonal antibodies directed specifically at disea …
  • Exiqon AS-医療機器分野:企業M&A・提携分析
    Summary Exiqon A/S (Exiqon), a subsidiary of Qiagen NV is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company’s product categories include microRNA research, incRNA research, mRNA research, DNA research, custom oligos and other reagent pro …
  • Svenska Cellulosa Aktiebolaget:企業のM&A・事業提携・投資動向
    Svenska Cellulosa Aktiebolaget - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Svenska Cellulosa Aktiebolaget Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Far Eastone Telecommunications Co Ltd (4904):企業の財務・戦略的SWOT分析
    Far Eastone Telecommunications Co Ltd (4904) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • The American Energy Group Ltd (AEGG):企業の財務・戦略的SWOT分析
    Summary The American Energy Group Ltd (American Energy Group), is an oil and natural gas company that develops, explores, acquire, and produces oil and natural gas producing assets. The company owns interest in two oil and gas leases in Southeast Texas American Energy Group's portfolio consists of e …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆